HDAC1 knockdown inhibits invasion and induces apoptosis in non-small cell lung cancer cells

References

Cacan, E. (2016). Histone deacetylase-1-mediated suppression of FAS in chemoresistant ovarian cancer cells. Anticancer Res. 36, 2819–2826.Search in Google Scholar

Campbell, A.M. and Decker, R.H. (2017). Mini-review of conventional and hypofractionated radiation therapy combined with immunotherapy for non-small cell lung cancer. Transl. Lung Cancer Res. 6, 220–229.10.21037/tlcr.2017.03.02Search in Google Scholar PubMed PubMed Central

Cao, L.L., Song, X., Pei, L., Liu, L., Wang, H., and Jia, M. (2017). Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer: a meta-analysis. Medicine (Baltimore) 96, e7663.10.1097/MD.0000000000007663Search in Google Scholar PubMed PubMed Central

Chen, J., Xu, Y., Tao, L., Pan, Y., Zhang, K., Wang, R., Chen, L.B., and Chu, X. (2017). MiRNA-26a contributes to the acquisition of malignant behaviors of doctaxel-resistant lung adenocarcinoma cells through targeting EZH2. Cell Physiol. Biochem. 41, 583–597.10.1159/000457879Search in Google Scholar PubMed

Eshelman, M.A., Shah, M., Raup-Konsavage, W.M., Rennoll, S.A., and Yochum, G.S. (2017). TCF7L1 recruits CtBP and HDAC1 to repress DICKKOPF4 gene expression in human colorectal cancer cells. Biochem. Biophys. Res. Commun. 487, 716–722.10.1016/j.bbrc.2017.04.123Search in Google Scholar PubMed

Huang, R.H., Quan, Y.J., Chen, J.H., Wang, T.F., Xu, M., Ye, M., Yuan, H., Zhang, C.J., Liu, X.J., and Min, Z.J. (2017). Osteopontin promotes cell migration and invasion, and inhibits apoptosis and autophagy in colorectal cancer by activating the p38 MAPK signaling pathway. Cell Physiol. Biochem. 41, 1851–1864.10.1159/000471933Search in Google Scholar PubMed

Li, Y. and Seto, E. (2016). HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb. Perspect Med. 6, a026831.10.1101/cshperspect.a026831Search in Google Scholar PubMed PubMed Central

Lin, C.W., Wang, L.K., Wang, S.P., Chang, Y.L., Wu, Y.Y., Chen, H.Y., Hsiao, T.H., Lai, W.Y., Lu, H.H., Chang, Y.H., et al. (2017). Corrigendum: Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1a/HDAC1/Slug axis. Nat. Commun. 8, 14502.10.1038/ncomms14502Search in Google Scholar PubMed PubMed Central

Mao, G., Jin, H., and Wu, L. (2017). DDX23-Linc00630-HDAC1 axis activates the Notch pathway to promote metastasis. Oncotarget 8, 38937–38949.10.18632/oncotarget.17156Search in Google Scholar PubMed PubMed Central

Paleiron, N., Bylicki, O., Andre, M., Riviere, E., Grassin, F., Robinet, G., and Chouaid, C. (2016). Targeted therapy for localized non-small-cell lung cancer: a review. Onco. Targets Ther. 9, 4099–4104.10.2147/OTT.S104938Search in Google Scholar PubMed PubMed Central

Pinkerneil, M., Hoffmann, M.J., Kohlhof, H., Schulz, W.A., and Niegisch, G. (2016). Evaluation of the therapeutic potential of the novel isotype specific HDAC inhibitor 4SC-202 in urothelial carcinoma cell lines. Target Oncol. 11, 783–798.10.1007/s11523-016-0444-7Search in Google Scholar PubMed PubMed Central

Roche, J. and Bertrand, P. (2016). Inside HDACs with more selective HDAC inhibitors. Eur. J. Med. Chem. 121, 451–483.10.1016/j.ejmech.2016.05.047Search in Google Scholar PubMed

Ruiz-Banobre, J., Perez-Pampin, E., Garcia-Gonzalez, J., Gomez-Caamano, A., Baron-Duarte, F.J., Lopez-Lopez, R., and Vazquez-Rivera, F. (2017). Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature. Lung Cancer 108, 217–221.10.1016/j.lungcan.2017.04.007Search in Google Scholar PubMed

Selokar, N.L., St John, L., Revay, T., King, W.A., Singla, S.K., and Madan, P. (2013). Effect of histone deacetylase inhibitor valproic acid treatment on donor cell growth characteristics, cell cycle arrest, apoptosis, and handmade cloned bovine embryo production efficiency. Cell Reprogram. 15, 531–542.10.1089/cell.2013.0018Search in Google Scholar PubMed

Stojanovic, N., Hassan, Z., Wirth, M., Wenzel, P., Beyer, M., Schafer, C., Brand, P., Kroemer, A., Stauber, R.H., Schmid, R.M., et al. (2017). HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer. Oncogene 36, 1804–1815.10.1038/onc.2016.344Search in Google Scholar PubMed

Tang, Z., Ding, S., Huang, H., Luo, P., Qing, B., Zhang, S., and Tang, R. (2017). HDAC1 triggers the proliferation and migration of breast cancer cells via upregulation of interleukin-8. Biol. Chem. 398, 1347–1356.10.1515/hsz-2017-0155Search in Google Scholar PubMed

Tharkar-Promod, S., Johnson, D.P., Bennett, S.E., Dennis, E.M., Banowsky, B.G., Jones, S.S., Shearstone, J.R., Quayle, S.N., Min, C., Jarpe, M., et al. (2017). HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia. Leukemia 32, 49–60.10.1038/leu.2017.174Search in Google Scholar PubMed PubMed Central

Wang, L., Bao, X., Yang, J., Li, H., Zhou, Q., Jiang, X., Li, M., Liu, X., Yuan, X., Sun, Y., et al. (2016). Novel cinnamohydroxamic acid derivatives as HDAC inhibitors with anticancer activity in vitro and in vivo. Chem. Biol. Interact. 249, 64–70.10.1016/j.cbi.2016.02.018Search in Google Scholar PubMed

Wang, X.Q., Bai, H.M., Li, S.T., Sun, H., Min, L.Z., Tao, B.B., Zhong, J., and Li, B. (2017). Knockdown of HDAC1 expression suppresses invasion and induces apoptosis in glioma cells. Oncotarget 8, 48027–48040.10.18632/oncotarget.18227Search in Google Scholar PubMed PubMed Central

Witt, A.E., Lee, C.W., Lee, T.I., Azzam, D.J., Wang, B., Caslini, C., Petrocca, F., Grosso, J., Jones, M., Cohick, E.B., et al. (2017). Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer. Oncogene 36, 1707–1720.10.1038/onc.2016.337Search in Google Scholar PubMed PubMed Central

Wood, K., Hensing, T., Malik, R., and Salgia, R. (2016). Prognostic and predictive value in KRAS in non-small-cell lung cancer: a review. J. Am. Med. Assoc. Oncol. 2, 805–812.Search in Google Scholar

Ye, T., Xu, J., Du, L., Mo, W., Liang, Y., and Xia, J. (2017). Downregulation of UBAP2L inhibits the epithelial-mesenchymal transition via SNAIL1 regulation in hepatocellular carcinoma cells. Cell Physiol. Biochem. 41, 1584–1595.10.1159/000470824Search in Google Scholar PubMed

Zhang, Q., Song, Y., Chen, W., Wang, X., Miao, Z., Cao, L., Li, F., and Wang, G. (2015). By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer. Oncotarget 6, 16461–16470.10.18632/oncotarget.3889Search in Google Scholar PubMed PubMed Central

Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., and Xu, Z. (2017). The role of tumoral FOXP3 on cell proliferation, migration, and invasion in gastric cancer. Cell Physiol. Biochem. 42, 1739–1754.10.1159/000479442Search in Google Scholar PubMed

Zhao, J. and Lei, H. (2016). Tripartite motif protein 72 regulates the proliferation and migration of rat cardiac fibroblasts via the transforming growth factor-β signaling pathway. Cardiology 134, 340–346.10.1159/000443703Search in Google Scholar PubMed